# OnCo record ab-science (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ab-science/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ab-science" ;
  schema:name "AB Science"@en ;
  schema:alternateName "AB Science S.A."@en ;
  schema:description "AB Science is a Paris biotechnology company built around masitinib, an oral tyrosine kinase inhibitor aimed at mast cells and macrophages that it has tested in phase 3 trials across cancers and neurological diseases."@en ;
  schema:url <https://onco.cc/companies/ab-science/>, <https://www.ab-science.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.ab-science.com>, <https://clinicaltrials.gov/search?lead=AB%20Science>, <https://en.wikipedia.org/wiki/AB_Science> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/gist/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:trials <https://onco.cc/trials/nct05211570/> .